Objective
=========

Bacteremia caused by *Acinetobacter baumannii*has an increasing incidence among critically ill patients. However, it is not clear whether it is associated with a higher mortality since controversial results have been reported. Increased mortality rate has been shown in some studies \[[@B1]\], whereas in others *A. baumannii*bacteremia does not alter the outcome \[[@B2]\]. The aim of this study was to evaluate the clinical impact of *A. baumannii*bacteremia on the outcome of patients in our ICU.

Patients and methods
====================

During a 4-month period (August--December 2004), in a 30-bed multidisciplinary ICU, patients who developed *A. baumannii*bacteremia and control patients without microbiological evidence of bacteremia were prospectively studied. Matching of control patients (1:2 ratio) was made on the basis of the APACHE II score (± 2 points) and diagnostic category.

Results
=======

During the study period, *A. baumannii*bacteremia was diagnosed in 21 patients (59 ± 15 years, mean ± standard deviation), admitted to the ICU (incidence 9.3 per 100 admissions). The APACHE II score in case and control patients was 19.9 ± 4.5 and 19.6 ± 4.8, respectively. The median interval from admission to the *A. baumannii*bacteremia was 10.5 days. *A. baumanii*strains were resistant to all antibiotics but susceptible to imipenem/cilastin and colistin. The ICU length of stay was 37 (23--51) days and 9 (1.8--16.2) days, median (95% confidence interval), for case and control patients, respectively, *P*\< 0.001. Case patients had a longer duration of mechanical ventilation versus control: 21 (9--53) days versus 5 (2--18) days, respectively, *P*\< 0.001. No differences between case and control patients were found in gender and age. Patients with *A. baumannii*bacteremia had significantly higher mortality than controls (38.1% vs 7.15%, *P*= 0.004). Logistic regression analysis showed that risk factors that were independently associated with adverse outcome were the presence of bacteremia (odds ratio = 10.2, *P*= 0.013), and multisystem organ failure (odds ratio = 20.9, *P*= 0.001).

Conclusions
===========

In this group of critically ill patients, after adjustment for severity of acute illness, *A. baumannii*bacteremia was associated with a significantly increased mortality rate compared with matched control patients. Whether other factors contribute to this increase has to be examined.
